DANA, Indonesia's E-Wallet Leader, and Ant International Launch Digital Sustainability Initiative Supported by Konservasi Indonesia for Marine Conservation
10.10.2025 07:24:00 CEST | Business Wire | Press Release
DANA and Ant International, together with Konservasi International, today unveiled the Ocean Buddy initiative, an interactive in-app mini program to raise awareness and drive long-term public participation in marine conservation among DANA's 200 million users in Indonesia. The launch was announced at the International Union for Conservation of Nature (IUCN) World Conservation Congress 2025 in Abu Dhabi.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251009459552/en/
From left to right: Ms Sabrina Peng, Senior Vice President, Chief Sustainability Officer, Ant Group, Mr Vince Iswara, CEO & Co-Founder of DANA Indonesia, Dr. Sylvia Earle, Founder and Chair, Mission Blue, Mr Eric Jing, Chairman, Ant Group
Inspired by Ant Forest, a global pioneer for digitally-driven environmental advocacy, Ocean Buddy leverages gamification incentives and lively visual designs to enhance broad-based, long-term user participation in conservation efforts, specifically the protection of whale sharks along the southern coast of Java.
Innovation and Collaboration for Broad-Based Sustainability Action
Ocean Buddy underlines DANA's ESG focus on building climate resilience for its business and the wider Indonesian community through proactive analysis and responsible action. As the world’s largest archipelagic state, Indonesia is home to the world’s largest whale shark population, a plankton-feeding species critical to maintain global ecological balance. According to Konservasi Indonesia, whale shark populations across the Indo-Pacific have declined by up to 63 percent over the last 75 years due to stranding and other threats.
The project is also the latest collaborative project under Programme Sirius, Ant International's flagship programme where 13 global e-wallet leaders, including DANA, join hands to make sustainability inclusive and accessible through digital innovation.
Ant International launched its new Sustainability Framework in June 2025, with a focus on collaborative sustainability, inclusion and trust initiatives across its payment and fintech business pillars. In 2024, Programme Sirius launched AquaViva at COP29, a global programme focused on scaling marine conservation through open collaboration.
Vince Iswara, CEO & Co-Founder of DANA Indonesia, said, “Environmental issues are becoming increasingly urgent. Now is the time for the fintech industry to play an active role in bringing forward technology that supports sustainability. Through the Ocean Buddy initiative, we want to prove that technological innovation is not only an engine for economic growth; it is also a powerful gateway to popular participation in protecting our marine and land ecosystems, to a sustainable as well as prosperous future for generations to come."
Leiming Chen, Chief Sustainability Officer, Ant International, said: “Ant International's mission is to build inclusive, sustainable growth through innovation and open collaboration. We are thrilled to support industry leaders like DANA to achieve sustainability and growth goals for the world's diverse communities. Through co-building innovative solutions and learning from each other, together we will be able to build a greener and more prosperous future from local to global.”
“The presence of whale sharks is closely tied to the health of Indonesia’s oceans. Konservasi Indonesia supports DANA through the Ocean Buddy program by sharing scientific knowledge while encouraging people to realize that simple actions can make a real contribution. With collective awareness and cross-sector collaboration, we believe that efforts to protect the oceans can become stronger and more sustainable,” explained Tinton Galih Yudhianto, Director of Partnership and Communications at Konservasi Indonesia.
Through Ocean Buddy’s cumulative-score ranking and an Impact Coins system, DANA users' everyday online activities are translated into offline conservation projects, including first response training for stranded marine mammals and the protection of whale shark habitats. All educational content under Ocean Buddy is verified by Konservasi Indonesia.
The partners plan to continue expanding Ocean Buddy's coverage and partnership circle, and evolve new features to drive nationwide conservation advocacy and action.
About DANA
DANA (PT Espay Debit Indonesia Koe) is a digital wallet-based technology financial company that provides payment platforms and financial services in Indonesia. Since its launch in December 2018, DANA has now reached more than 200 million users in Indonesia. DANA provides complete digital transaction solutions that are safe, easy and convenient for users, merchants and financial institutions. The DANA solution, developed by leading financial technology engineers in Indonesia, aims to advance and accelerate financial literacy and inclusion in Indonesia. Apart from empowering digital finance, DANA also seeks to encourage Indonesian society through impactful social initiatives that focus on empowering women and preserving the environment.
About Ant International
With headquarters in Singapore and main operations across Asia, Europe, the Middle East and Latin America, Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions.
To learn more, please visit https://www.ant-intl.com/
About Konservasi Indonesia
Konservasi Indonesia is a national foundation that aims to support the sustainable development and protection of critical ecosystems in Indonesia. We believe in the importance of multi-stakeholder partnerships across sectors and jurisdictions. Working in partnership with the government and others, we design and deliver innovative nature-based solutions to climate change, using a sustainable landscapes-seascapes approach to create lasting impacts for people and nature. More information visit: www.konservasi-id.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20251009459552/en/
Contacts
Media Contacts:
Zen Soo
Ant International
zen.s@ant-intl.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press Release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press Release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press Release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom